MedPath

A Device for Rapid, Painless, Bedside Muscle Evaluation of Children

Completed
Conditions
Duchenne Muscular Dystrophy
Registration Number
NCT02340923
Lead Sponsor
Skulpt, Inc.
Brief Summary

The purpose of this protocol is to perform Electrical Impedance Myography (EIM) testing on healthy children and children with duchenne muscular dystrophy so as to develop a new, convenient tool for the office based assessment of children with a wide variety of neuromuscular conditions.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
327
Inclusion Criteria
    1. Age 0-18
    1. Male
    1. Genetic or histopathologic diagnosis of duchenne muscular dystrophy, or signs and symptoms of DMD and genetic or histopathologic diagnosis in a family member.
Exclusion Criteria
    1. Age over 18
    1. Female
    1. Presence of a superimposed neuromuscular or other medical condition that substantially impacts the individual's health or ability to cooperate.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Electrical Impedance Myography MeasurementsBaseline (all subjects) & 3 months, 6 months, 1 year for returning subjects only

Up to 11 muscles will be measured using EIM technology. These muscles include: Right Lateral Deltoid, Right Biceps, Right Triceps, Right Wrist Flexors, Right Wrist Extensors, Right Vastus Lateralis, Right Tibialis Anterior, Right Gastrocnemius, Right Gluteus Medius, Right Biceps Femoris, and Right Thoracic Parapinal.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (5)

Boston Children's Hospital

🇺🇸

Boston, Massachusetts, United States

St. Louis Children's Hospital

🇺🇸

St. Louis, Missouri, United States

Cincinnati Children's Hospital

🇺🇸

Cincinnati, Ohio, United States

Children's Hospital Colorado

🇺🇸

Aurora, Colorado, United States

Skulpt, Inc.

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath